David A. Kass is at Halsted 500, Johns Hopkins Medical Institutions, 600 N. Wolfe Street, Baltimore, Maryland 21287, USA. dkass@jhmi.edu
A polymorphism present in about half the general population can predispose to heart failure as well as enhance responsiveness to -blockers. The mechanism for this is now being revealed (pages 1300−1305).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated